Pharmaceutical

Solid tumours: CAR-T therapies’ Waterloo

Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.

May 30, 2025 - 06:00
Solid tumours: CAR-T therapies’ Waterloo
Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.
Read the original article

Tags:

Previous Article

The impact of drug pricing and reimbursement on the pharmaceutical industry

Next Article

Regeneron to deploy Telesis Bio’s Gibson SOLA at R&D facilities

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Quitting alcohol — or even drinking less — reduces risk of oral cavity and esophageal cancer, per new analysis

Quitting alcohol — or even drinking less — reduces risk...

Dec 27, 2023

Opinion: What does ‘bona fide competition’ actually mean in the biologics market?

Opinion: What does ‘bona fide competition’ actually mea...

Sep 6, 2023

STAT+: How a key Senate committee is planning to regulate pharmacy benefit managers

STAT+: How a key Senate committee is planning to regula...

Jul 14, 2023